PH-ILD - tyvaso
Treatment options for ILDs include immunosuppressive med- ications, anti-fibrotic drugs, supplemental oxygen therapy and pulmonary ...
The identification and management of interstitial lung disease in ...6.3 Treatment for PF-ILD?? The anti-fibrotic agents might prevent disease progression of RA-ILD. Nintedanib is an intracellular inhibitor of tyrosine kinases and ... Cyclophosphamide for interstitial lung disease-associated acute ...Introduction: This pooled analysis of nine phase I and II trastuzumab deruxtecan (T-DXd) monotherapy studies. Diagnosis and Management of Fibrotic Interstitial Lung DiseaseCommonly used agents include cyclophosphamide (CYC), mycophenolate mofetil (MMF), rituximab (RTX), azathioprine (AZA), tocilizumab, methotrexate and prednisone.
Autres Cours:
